Effect of subcutaneous tocilizumab on gene expression of neutrophils in fibromyalgia patients
Differentially expressed genes were identified in neutrophils of 5 primary FM patients, when compared with controls. Differentially expressed genes were also identified in neutrophils of 2 primary FM patients at baseline and 12 weeks after tocilizumab treatment. Overall design: Comparative gene expression profiling analysis of RNA-seq data for blood neutrophils.